Dose-ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis

Clinical trial NCT00504426 · COMPLETED

Trial details

NCT number: NCT00504426
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pain Due to Osteoporosis

Start date: 2007-07-01
Primary completion: 2008-07-01
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.